-
Carcinosarcoma of the uterus is a rare condition accounting for less that 4% of all uterine neoplasms. Previous work has identified that the most active single agents are platinum, ifosfamide, paclitaxel, and doxorubicin.
-
Without fanfare, the FDA approved oral tranexamic acid tablets (Lysteda), the first non-hormonal product cleared to treat heavy menstrual bleeding in the United States.
-
In this issue: Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
-
-
I love this article. It's relevant to our daily practice, but, more importantly, it verbalizes the same issues that both physicians and patients want clarified.
-
In this issue: Aggressive approach to CVD reduces MI, folic acid and vitamin B12 for CAD, corticosteroids for acute exacerbations of COPD, prescription drug abuse among young adults, and ARBs and cancer risk.
-
National estimates of contraceptive use and method choice from the most recent 2006-2008 cycle of the National Surveys of Family Growth (NSFG) were compared to earlier estimates based on the 1982, 1995, and 2002 surveys.
-
In 1972, liggins and howie demonstrated that antenatal corticosteroids (ACS) stimulated the production of surfactant in premature human fetuses.
-
The primary purpose of this study was to develop a gene expression profile of BRCA dysfunction ("BRCAness"), which could be used to discriminate sporadic ovarian cancer patients with or without dysfunction to the homologous repair pathway and correlate whether this profile would describe sensitivity to platinum-based chemotherapy and pharmacological inhibition of poly-ADP ribose polymerase (PARP).
-
The U.S. medical eligibility criteria for contraceptive Use is a newly available, free, evidence-based resource for clinicians. This resource provides guidance to aid contraceptive decision-making for women (and men) with comorbidities.
